The American Society of Plastic Surgeons recommended on Tuesday that its members refrain from performing gender transition procedures on young patients until they reach age 19, a shift that comes at a time of mounting opposition to such care at the state and federal levels.

The group’s new position stands in contrast to those taken by most major medical associations in the United States, which endorse a range of treatments for adolescents and teenagers struggling with gender dysphoria.

The treatments include puberty-blocking drugs, hormone therapies and, in rarer cases, surgeries.

In its statement, the society said the new recommendations were prompted by what it described as a lack of quality research on the long-term outcomes for young people who had undergone surgical interventions like mastectomies and cited “emerging evidence of treatment complications and potential harms.

” The announcement drew praise from the Trump administration, which issued a statement commending the group for “disavowing pediatric sex-rejecting procedures.

” In the statement, Jim O’Neill, the deputy health secretary, said, “Today marks another victory for biological truth in the Trump administration

Highlighted sentences link to their corresponding claims. Click any highlighted sentence to jump to its detailed analysis.
Highlight Colors Indicate Claim Quality:
✓ Healthy Claim - No fallacies or contradictions detected
⚠️ Minor Issues - Has contradictions or minor fallacies
🚨 Serious Issues - Multiple contradictions or severe fallacies
Quality Criteria: Claims are evaluated for logical fallacies and contradictions with other news sources. Green highlights indicate healthy claims suitable for reference.
Source